Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in Hemodialyzed Black African Patients

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in Hemodialyzed Black African Patients

Context and Objective: Cardiovascular diseases are the leading cause of mortality in patients. In this context, proprotein convertase subtilisin/kexin type 9 (PCSK9) appears to be the new biomarker identified as interfering in lipid homeostasis. This study aimed to investigate the association betwee...

Full description

Bibliographic Details
Main Authors: François-Pantaléon Musungayi Kajingulu, François Bompeka Lepira, Aliocha Natuhoyila Nkodila, Jean-Robert Rissassy Makulo, Vieux Momeme Mokoli, Pepe Mfutu Ekulu, Justine Busanga Bukabau, Yannick Mayamba Nlandu, Augustin Luzayadio Longo, Nazaire Mangani Nseka, Ernest Kiswaya Sumaili
Format: Article
Language:English
Published: Rambam Health Care Campus 2021-07-01
Series:Rambam Maimonides Medical Journal
Subjects:
black africans
cardiovascular events
hemodialysis
kidney disease
proprotein convertase subtilisin
kexin type 9
Online Access:https://www.rmmj.org.il/issues/50/1212/manuscript

Internet

https://www.rmmj.org.il/issues/50/1212/manuscript

Similar Items